Synovex
Medford
About Synovex
Synovex is developing a next generation, non-immunosuppressive treatment for fibrosis that occurs in fibrotic diseases and debilitating cartilage destruction in rheumatoid arthrits.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.5M
- Last round: Series Unknown (Oct 2012)
- Website: synovexcorp.com
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/synovex-2277719 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.